Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7005)
All Articles published online
|
Publishing Process of This Article
|
Aug 21, 2014 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Bilici A. Prognostic factors related with survival in patients with pancreatic adenocarcinoma. World J Gastroenterol 2014; 20(31): 10802-10812 [PMID: 25152583 DOI: 10.3748/wjg.v20.i31.10802] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v20/i31/10802.htm |
| Number | Citing Articles |
| 1 |
Mónika Lipp, Dorottya Tarján, Jimin Lee, Ádám Zolcsák, Eszter Szalai, Brigitta Teutsch, Nándor Faluhelyi, Bálint Erőss, Péter Hegyi, Alexandra Mikó. Fatty Pancreas Is a Risk Factor for Pancreatic Cancer: A Systematic Review and Meta-Analysis of 2956 Patients. Cancers 2023; 15(19): 4876 doi: 10.3390/cancers15194876
|
| 2 |
Rubeshen Pillay Arnachellum, Melanie Cariou, Jean-Baptiste Nousbaum, Julien Jezequel, Jean Yves Le Reste, Michel Robaszkiewicz. Pancreatic Adenocarcinoma in the Finistère Area, France, Between 2002 and 2011 (1002 Cases). Pancreas 2016; 45(7): 953 doi: 10.1097/MPA.0000000000000594
|
| 3 |
Sarang Hong, Ki Byung Song, Dae Wook Hwang, Jae Hoon Lee, Woohyung Lee, Eunsung Jun, Jaewoo Kwon, Yejong Park, Seo Young Park, Naru Kim, Dakyum Shin, Hyeyeon Kim, Minkyu Sung, Yunbeom Ryu, Song Cheol Kim. Preoperative serum carbohydrate antigen 19-9 levels predict early recurrence after the resection of early-stage pancreatic ductal adenocarcinoma. World Journal of Gastrointestinal Surgery 2021; 13(11): 1423-1435 doi: 10.4240/wjgs.v13.i11.1423
|
| 4 |
Qingqing Wang, Qichao Ni, Xudong Wang, Huijun Zhu, Zhiwei Wang, Jianfei Huang. High expression of RAB27A and TP53 in pancreatic cancer predicts poor survival. Medical Oncology 2015; 32(1) doi: 10.1007/s12032-014-0372-2
|
| 5 |
Shengnan Li, Gengpu Zhang, Yang Lu, Tiansuo Zhao, Chuntao Gao, Weishuai Liu, Yongjun Piao, Yanan Chen, Chongbiao Huang, Antao Chang, Jihui Hao. Perioperative Serum Scoring Systems Predict Early Recurrence and Poor Prognosis of Resectable Pancreatic Cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.841819
|
| 6 |
Pablo Sala Elarre, Esther Oyaga-Iriarte, Kenneth H. Yu, Vicky Baudin, Leire Arbea Moreno, Omar Carranza, Ana Chopitea Ortega, Mariano Ponz-Sarvise, Luis D. Mejías Sosa, Fernando Rotellar Sastre, Blanca Larrea Leoz, Yohana Iragorri Barberena, Jose C. Subtil Iñigo, Alberto Benito Boíllos, Fernando Pardo, Javier Rodríguez Rodríguez. Use of Machine-Learning Algorithms in Intensified Preoperative Therapy of Pancreatic Cancer to Predict Individual Risk of Relapse. Cancers 2019; 11(5): 606 doi: 10.3390/cancers11050606
|
| 7 |
Klaus Felix, Ulf Hinz, Sophie Dobiasch, Thilo Hackert, Frank Bergmann, Magnus Neumüller, Simon Gronowitz, Mattias Bergqvist, Oliver Strobel. Preoperative Serum Thymidine Kinase Activity as Novel Monitoring, Prognostic, and Predictive Biomarker in Pancreatic Cancer. Pancreas 2018; 47(1): 72 doi: 10.1097/MPA.0000000000000966
|
| 8 |
Wei Fang Dai, Jaclyn Beca, Helen Guo, Wanrudee Isaranawatchai, Deborah Schwartz, Rohini Naipaul, Jessica Arias, Yao Qiao, Scott Gavura, Ruby Redmond‐Misner, Zahra Ismail, Lisa Barbera, Kelvin Chan. Are population‐based patient‐reported outcomes associated with overall survival in patients with advanced pancreatic cancer?. Cancer Medicine 2020; 9(1): 215 doi: 10.1002/cam4.2704
|
| 9 |
Ricardo P. Martinho, Qingjia Bao, Stefan Markovic, Dina Preise, Keren Sasson, Lilach Agemy, Avigdor Scherz, Lucio Frydman. Identification of variable stages in murine pancreatic tumors by a multiparametric approach employing hyperpolarized 13C MRSI, 1H diffusivity and 1H T1 MRI. NMR in Biomedicine 2021; 34(2) doi: 10.1002/nbm.4446
|
| 10 |
Ferdinando De Vita, Jole Ventriglia, Antonio Febbraro, Maria Maddalena Laterza, Alessio Fabozzi, Beatrice Savastano, Angelica Petrillo, Anna Diana, Guido Giordano, Teresa Troiani, Giovanni Conzo, Gennaro Galizia, Fortunato Ciardiello, Michele Orditura. NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practice. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2671-9
|
| 11 |
Weihong Wang, Chanyoon Park, Eunseok Oh, Youjung Sung, Jusung Lee, Kyu-Hyung Park, Heonjoong Kang. Benzophenone Compounds, from a Marine-Derived Strain of the Fungus Pestalotiopsis neglecta, Inhibit Proliferation of Pancreatic Cancer Cells by Targeting the MEK/ERK Pathway. Journal of Natural Products 2019; 82(12): 3357 doi: 10.1021/acs.jnatprod.9b00646
|
| 12 |
Alexander W. Coombs, Chloe Jordan, Sabba A. Hussain, Omar Ghandour. Scoring systems for the management of oncological hepato-pancreato-biliary patients. Annals of Hepato-Biliary-Pancreatic Surgery 2022; 26(1): 17 doi: 10.14701/ahbps.21-113
|
| 13 |
Raju Kandimalla, Hideo Tomihara, Jasjit K. Banwait, Kensuke Yamamura, Gagandeep Singh, Hideo Baba, Ajay Goel. A 15-Gene Immune, Stromal, and Proliferation Gene Signature that Significantly Associates with Poor Survival in Patients with Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research 2020; 26(14): 3641 doi: 10.1158/1078-0432.CCR-19-4044
|
| 14 |
Joo Kyung Park, Hyemin Kim, Dae-Soon Son, Nayoung K. D. Kim, Young Kyung Sung, Minseob Cho, Chung Lee, Dong Hyo Noh, Se-Hoon Lee, Kyu Taek Lee, Jong Kyun Lee, Kee-Taek Jang, Woong-Yang Park, Kwang Hyuck Lee. Accurate Prognosis Prediction of Pancreatic Ductal Adenocarcinoma Using Integrated Clinico-Genomic Data of Endoscopic Ultrasound-Guided Fine Needle Biopsy. Cancers 2021; 13(11): 2791 doi: 10.3390/cancers13112791
|
| 15 |
Dimitrios Schizas, Alkmini Koumpoura, Meropi Galari, Panagiota Economopoulou, Michail Vailas, Maria Sotiropoulou, Dimitrios Dimitroulis, Ioannis Maroulis, Evangelos Felekouras. A personalized approach to pancreatic ductal adenocarcinoma and its application in surgical practice. Personalized Medicine 2021; 18(6): 613 doi: 10.2217/pme-2021-0031
|
| 16 |
Christof Kaltenmeier, Ibrahim Nassour, Richard S. Hoehn, Sidrah Khan, Alison Althans, David A. Geller, Alessandro Paniccia, Amer Zureikat, Samer Tohme. Impact of Resection Margin Status in Patients with Pancreatic Cancer: a National Cohort Study. Journal of Gastrointestinal Surgery 2021; 25(9): 2307 doi: 10.1007/s11605-020-04870-6
|
| 17 |
Roberto Arrigoni, Andrea Ballini, Luigi Santacroce , Stefania Cantore, Angelo Inchingolo, Francesco Inchingolo , Marina Di Domenico , Lucio Quagliuolo , Mariarosaria Boccellino . Another Look at Dietary Polyphenols: Challenges in Cancer Prevention
and Treatment. Current Medicinal Chemistry 2022; 29(6): 1061 doi: 10.2174/0929867328666210810154732
|
| 18 |
Fatima Ezzahra Bennani, Latifa Doudach, Khalid Karrouchi, Youssef El rhayam, Christopher E. Rudd, M'hammed Ansar, My El Abbes Faouzi. 2D-QSAR study and design of novel pyrazole derivatives as an anticancer lead compound against A-549, MCF-7, HeLa, HepG-2, PaCa-2, DLD-1. Computational Toxicology 2023; 26: 100265 doi: 10.1016/j.comtox.2023.100265
|
| 19 |
Ebba Asplund, Mattias Bergqvist, Maura Krook, J.-Matthias Löhr. Plasma thymidine kinase activity as a prognostic biomarker in pancreatic ductal adenocarcinoma: a single-center prospective study. Scandinavian Journal of Gastroenterology 2023; 58(9): 1044 doi: 10.1080/00365521.2023.2198057
|
| 20 |
Haiqun Xing, Zhixin Hao, Wenjia Zhu, Dehui Sun, Jie Ding, Hui Zhang, Yu Liu, Li Huo. Preoperative prediction of pathological grade in pancreatic ductal adenocarcinoma based on 18F-FDG PET/CT radiomics. EJNMMI Research 2021; 11(1) doi: 10.1186/s13550-021-00760-3
|
| 21 |
Shinichi Ikuta, Tsukasa Aihara, Naoki Yamanaka. Preoperative C‐reactive protein to albumin ratio is a predictor of survival after pancreatic resection for pancreatic ductal adenocarcinoma. Asia-Pacific Journal of Clinical Oncology 2019; 15(5) doi: 10.1111/ajco.13123
|
| 22 |
MA Çaparlar, A Durhan, M Süleymanov, C Binarbaşı, K Koşmaz. Prognostic Effect of Preoperative Inflammatory Markers on Morbidity and Overall Survival in Pancreatic Adenocarsinoma. Nigerian Journal of Clinical Practice 2023; 26(12): 1902 doi: 10.4103/njcp.njcp_426_23
|
| 23 |
Michael Schneider, Ismail Labgaa, Dionisios Vrochides, Alessandro Zerbi, Gennaro Nappo, Julie Perinel, Mustapha Adham, Stijn van Roessel, Marc Besselink, J. Sven D. Mieog, Jesse V. Groen, Nicolas Demartines, Markus Schäfer, Gaëtan-Romain Joliat. External validation of three lymph node ratio-based nomograms predicting survival using an international cohort of patients with resected pancreatic head ductal adenocarcinoma. European Journal of Surgical Oncology 2022; 48(9): 2002 doi: 10.1016/j.ejso.2022.05.002
|
| 24 |
Hui Zhao, Qingqing Wang, Xudong Wang, Huijun Zhu, Shu Zhang, Wei Wang, Zhiwei Wang, Jianfei Huang. Correlation Between RAB27B and p53 Expression and Overall Survival in Pancreatic Cancer. Pancreas 2016; 45(2): 204 doi: 10.1097/MPA.0000000000000453
|
| 25 |
Hye Jin Kim, Mi-Suk Park, Jin Yong Lee, Kyunghwa Han, Yong Eun Chung, Jin-Young Choi, Myeong-Jin Kim, Chang Moo Kang. Incremental Role of Pancreatic Magnetic Resonance Imaging after Staging Computed Tomography to Evaluate Patients with Pancreatic Ductal Adenocarcinoma. Cancer Research and Treatment 2019; 51(1): 24 doi: 10.4143/crt.2017.404
|
| 26 |
Zibo Meng, Mingsi Cao, Yushun Zhang, Zhiqiang Liu, Shihong Wu, Heshui Wu. Tumor location as an indicator of survival in T1 resectable pancreatic ductal adenocarcinoma: a propensity score-matched analysis. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-0975-3
|
| 27 |
Hongxing Gui, Christopher P. Julien, Suehyb G. Alkhatib, Michael A. Husson. An indolent pancreatic ductal adenocarcinoma with psammoma bodies and a coincidental neuroendocrine tumor. Human Pathology: Case Reports 2019; 16: 100286 doi: 10.1016/j.ehpc.2019.01.005
|
| 28 |
Angus G Dalgleish, Justin Stebbing, Douglas JA Adamson, Seema Safia Arif, Paolo Bidoli, David Chang, Sue Cheeseman, Robert Diaz-Beveridge, Carlos Fernandez-Martos, Rob Glynne-Jones, Cristina Granetto, Bartomeu Massuti, Karen McAdam, Raymond McDermott, Andrés J Muñoz Martín, Demetris Papamichael, Roberto Pazo-Cid, Jose M Vieitez, Alberto Zaniboni, Kevin J Carroll, Shama Wagle, Andrew Gaya, Satvinder S Mudan. Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer. British Journal of Cancer 2016; 115(7): 789 doi: 10.1038/bjc.2016.271
|
| 29 |
Bolun Jiang, Li Zhou, Jun Lu, Yizhi Wang, Chengxi Liu, Zhiyong Liang, Weixun Zhou, Lei You, Junchao Guo. Clinicopathological and prognostic significance of ubiquitin‐specific peptidase 15 and its relationship with transforming growth factor‐β receptors in patients with pancreatic ductal adenocarcinoma. Journal of Gastroenterology and Hepatology 2021; 36(2): 507 doi: 10.1111/jgh.15244
|
| 30 |
Huaqiang Ouyang, Weidong Ma, Fang Liu, Zhensong Yue, Minghui Fang, Manman Quan, Zhanyu Pan. Factors influencing survival of patients with pancreatic adenocarcinoma and synchronous liver metastases receiving palliative care. Pancreatology 2017; 17(5): 773 doi: 10.1016/j.pan.2017.07.002
|
| 31 |
Zev A. Wainberg, Kynan Feeney, Myung Ah Lee, Andrés Muñoz, Antonio Cubillo Gracián, Sara Lonardi, Baek-Yeol Ryoo, Annie Hung, Yong Lin, Johanna Bendell, J. Randolph Hecht. Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing first-line gemcitabine-containing therapy: effect of performance status and comparison with other regimens. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07110-x
|
| 32 |
Cameron J. Herting, Isaac Karpovsky, Gregory B. Lesinski. The tumor microenvironment in pancreatic ductal adenocarcinoma: current perspectives and future directions. Cancer and Metastasis Reviews 2021; 40(3): 675 doi: 10.1007/s10555-021-09988-w
|
| 33 |
Mahdi Sheikh, Sahar Masoudi, Razieh Bakhshandeh, Alireza Moayyedkazemi, Farhad Zamani, Sepideh Nikfam, Masoumeh Mansouri, Neda Ghamarzad Shishavan, Saman Nikeghbalian, Paul Brennan, Reza Malekzadeh, Akram Pourshams, Ulrich Wellner. Survival features, prognostic factors, and determinants of diagnosis and treatment among Iranian patients with pancreatic cancer, a prospective study. PLOS ONE 2020; 15(12): e0243511 doi: 10.1371/journal.pone.0243511
|
| 34 |
Moon Hyung Choi, Young Joon Lee, Seung Bae Yoon, Joon-Il Choi, Seung Eun Jung, Sung Eun Rha. MRI of pancreatic ductal adenocarcinoma: texture analysis of T2-weighted images for predicting long-term outcome. Abdominal Radiology 2019; 44(1): 122 doi: 10.1007/s00261-018-1681-2
|
| 35 |
David Goldstein, Daniel D. Von Hoff, E. Gabriela Chiorean, Michele Reni, Josep Tabernero, Ramesh K. Ramanathan, Marc Botteman, Abdalla Aly, Sandra Margunato-Debay, Brian Lu, Chrystal U. Louis, Desmond McGovern, Chee Khoon Lee. Nomogram for Estimating Overall Survival in Patients With Metastatic Pancreatic Cancer. Pancreas 2020; 49(6): 744 doi: 10.1097/MPA.0000000000001563
|
| 36 |
Fengming Ji, Qiang Kang, Lianmin Wang, Lixin Liu, Yang Ke, Ya Zhu, Naiqiang Zhang, Shifeng Xiong, Yuehua Li, Hao Zou. Prognostic significance of the neutrophil-to-lymphocyte ratio with distal cholangiocarcinoma patients. Medicine 2020; 99(43): e22827 doi: 10.1097/MD.0000000000022827
|
| 37 |
Yuki Hashimoto, Mitsuaki Ishida, Hironori Ryota, Tomohisa Yamamoto, Hisashi Kosaka, Satoshi Hirooka, So Yamaki, Masaya Kotsuka, Yoichi Matsui, Hiroaki Yanagimoto, Koji Tsuta, Sohei Satoi. Adipophilin expression is an indicator of poor prognosis in patients with pancreatic ductal adenocarcinoma: An immunohistochemical analysis. Pancreatology 2019; 19(3): 443 doi: 10.1016/j.pan.2019.03.001
|
| 38 |
Ambica Parmar, Jorge Chaves-Porras, Ronak Saluja, Kaitlyn Perry, Amanda P. Rahmadian, Seanthel Delos Santos, Yoo-Joung Ko, Scott Berry, Mark Doherty, Kelvin K.W. Chan. Adjuvant treatment for resected pancreatic adenocarcinoma: A systematic review and network meta-analysis. Critical Reviews in Oncology/Hematology 2020; 145: 102817 doi: 10.1016/j.critrevonc.2019.102817
|
| 39 |
Charlotte Maulat, Cindy Canivet, Célia Touraine, Sophie Gourgou, Bertrand Napoleon, Laurent Palazzo, Nicolas Flori, Guillaume Piessen, Pierre Guibert, Stéphanie Truant, Eric Assenat, Louis Buscail, Barbara Bournet, Fabrice Muscari. A New Score to Predict the Resectability of Pancreatic Adenocarcinoma: The BACAP Score. Cancers 2020; 12(4): 783 doi: 10.3390/cancers12040783
|
| 40 |
Ramadevi Subramani, Elizabeth Gonzalez, Arunkumar Arumugam, Sushmita Nandy, Viviana Gonzalez, Joshua Medel, Fernando Camacho, Andrew Ortega, Sandrine Bonkoungou, Mahesh Narayan, Alok kumar Dwivedi, Rajkumar Lakshmanaswamy. Nimbolide inhibits pancreatic cancer growth and metastasis through ROS-mediated apoptosis and inhibition of epithelial-to-mesenchymal transition. Scientific Reports 2016; 6(1) doi: 10.1038/srep19819
|
| 41 |
A.S. Guerard, A. Ayav, H. Busby, M. Lafitte, H. Rousseau, V. Laurent. Early liver metastases in resectable periampullary cancer: Incidence and risk factors. European Journal of Radiology 2017; 93: 265 doi: 10.1016/j.ejrad.2017.06.005
|
| 42 |
Sunnie Kim, James E. Signorovitch, Hongbo Yang, Oscar Patterson-Lomba, Cheryl Q. Xiang, Brian Ung, Monika Parisi, John L. Marshall. Comparative Effectiveness of nab-Paclitaxel Plus Gemcitabine vs FOLFIRINOX in Metastatic Pancreatic Cancer: A Retrospective Nationwide Chart Review in the United States. Advances in Therapy 2018; 35(10): 1564 doi: 10.1007/s12325-018-0784-z
|
| 43 |
J. Ventriglia, A. Petrillo, M. Huerta Alváro, M. M. Laterza, B. Savastano, V. Gambardella, G. Tirino, L. Pompella, A. Diana, F. Iovino, T. Troiani, E. Martinelli, F. Morgillo, M. Orditura, A. Cervantes, F. Ciardiello, F. De Vita. Neutrophil to Lymphocyte Ratio as a Predictor of Poor Prognosis in Metastatic Pancreatic Cancer Patients Treated with Nab-Paclitaxel plus Gemcitabine: A Propensity Score Analysis. Gastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/2373868
|
| 44 |
Lili Su, Guang Liu, Ying Guo, Xuanping Zhang, Xiaoyan Zhu, Jiayin Wang. Integration of Protein-Protein Interaction Networks and Gene Expression Profiles Helps Detect Pancreatic Adenocarcinoma Candidate Genes. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.854661
|
| 45 |
Sae-Jin Park, Jung Hoon Kim, Seo-Youn Choi, Ijin Joo. Important Radiologic and Clinical Factors for Predicting Overall Survival in Pancreatic Adenocarcinoma Patients Who Underwent FOLFIRINOX. Pancreas 2024; doi: 10.1097/MPA.0000000000002330
|
| 46 |
Jiayu Liu, Nannan Song, Yibing Huang, Yuxin Chen. Irisin inhibits pancreatic cancer cell growth via the AMPK-mTOR pathway. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-33229-w
|
| 47 |
Ahmad Abu Turab Naqvi, Gulam Mustafa Hasan, Md Imtaiyaz Hassan. Investigating the role of transcription factors of pancreas development in pancreatic cancer. Pancreatology 2018; 18(2): 184 doi: 10.1016/j.pan.2017.12.013
|
| 48 |
Ying Zhu, Jianbo Tian, Xiating Peng, Xiaoyang Wang, Nan Yang, Pingting Ying, Haoxue Wang, Bin Li, Yue Li, Ming Zhang, Yimin Cai, Zequn Lu, Siyuan Niu, Yao Li, Rong Zhong, Jiang Chang, Xiaoping Miao. A genetic variant conferred high expression of CAV2 promotes pancreatic cancer progression and associates with poor prognosis. European Journal of Cancer 2021; 151: 94 doi: 10.1016/j.ejca.2021.04.008
|
| 49 |
Charles Tzu-Chi Lee, Jie-Xi Hu, Chin-Mei Liu. Exploring prior diseases associated with pancreatic cancer. Current Problems in Cancer 2021; 45(5): 100707 doi: 10.1016/j.currproblcancer.2021.100707
|
| 50 |
Hussein H. Khachfe, Joseph R. Habib, Ibrahim Nassour, Salem Al Harthi, Faek R. Jamali. Borderline Resectable and Locally Advanced Pancreatic Cancers. Pancreas 2021; 50(9): 1243 doi: 10.1097/MPA.0000000000001924
|
| 51 |
Hui Gan, Jiarong Lan, Hongxia Bei, Guangxing Xu. The impact of sarcopenia on prognosis of patients with pancreatic cancer: A systematic review and meta-analysis. Scottish Medical Journal 2023; 68(4): 133 doi: 10.1177/00369330231187655
|
| 52 |
Esther N. Pijnappel, J. Annelie Suurmeijer, Bas Groot Koerkamp, Milan Kos, Jens T. Siveke, Roberto Salvia, Paula Ghaneh, Casper H. J. van Eijck, Faridi S. van Etten-Jamaludin, Ross Abrams, Birute Brasiūnienė, Markus W. Büchler, Riccardo Casadei, Jean-Luc van Laethem, Jordan Berlin, Narikazu Boku, Thierry Conroy, Henriette Golcher, Marianne Sinn, John P. Neoptolemos, Geertjan van Tienhoven, Marc G. Besselink, Johanna W. Wilmink, Hanneke W. M. van Laarhoven. Consensus Statement on Mandatory Measurements for Pancreatic Cancer Trials for Patients With Resectable or Borderline Resectable Disease (COMM-PACT-RB). JAMA Oncology 2022; 8(6): 929 doi: 10.1001/jamaoncol.2022.0168
|
| 53 |
Chien-shan Cheng, Wei Liu, Liangping Zhou, Wei Tang, Ailing Zhong, Zhiqiang Meng, Lianyu Chen, Zhen Chen. Prognostic Predicting Role of Contrast-Enhanced Computed Tomography for Locally Advanced Pancreatic Adenocarcinoma. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/1356264
|
| 54 |
Bolun Jiang, Li Zhou, Jun Lu, Yizhi Wang, Chengxi Liu, Weixun Zhou, Junchao Guo. Elevated TIAM2 expression promotes tumor progression and is associated with unfavorable prognosis in pancreatic cancer. Scandinavian Journal of Gastroenterology 2021; 56(1): 59 doi: 10.1080/00365521.2020.1853806
|
| 55 |
Zengyu Feng, Peng Chen, Kexian Li, Jianyao Lou, Yulian Wu, Tao Li, Chenghong Peng. A Novel Ferroptosis-Related Gene Signature Predicts Recurrence in Patients With Pancreatic Ductal Adenocarcinoma. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.650264
|
| 56 |
Yu-Guang Chen, Hsueh-Hsing Pan, Ming-Shen Dai, Chin Lin, Chieh-Sheng Lu, Sui-Lung Su, Ping-Ying Chang, Tzu-Chuan Huang, Jia-Hong Chen, Yi-Ying Wu, Yeu-Chin Chen, Ching Liang Ho. Impact of Comorbidity and Age on Determinants Therapeutic Strategies in Advanced Pancreatic Head Cancer Patients With Obstructive Jaundices. Medicine 2015; 94(31): e1298 doi: 10.1097/MD.0000000000001298
|
| 57 |
Johanna Wennerblom, Pushpa Saksena, Claes Jönsson, Anders Thune. Lymph node 8a as a prognostic marker for poorer prognosis in pancreatic and periampullary carcinoma. Scandinavian Journal of Gastroenterology 2018; 53(2): 225 doi: 10.1080/00365521.2017.1417474
|
| 58 |
Raju Kandimalla, Tadanobu Shimura, Saurav Mallik, Fuminori Sonohara, Susan Tsai, Douglas B. Evans, Song Cheol Kim, Hideo Baba, Yasuhiro Kodera, Daniel Von Hoff, Xi Chen, Ajay Goel. Identification of Serum miRNA Signature and Establishment of a Nomogram for Risk Stratification in Patients With Pancreatic Ductal Adenocarcinoma. Annals of Surgery 2022; 275(1): e229 doi: 10.1097/SLA.0000000000003945
|
| 59 |
Weiyu Ge, Jingyu Ma, Tiebo Mao, Haiyan Xu, Xiaofei Zhang, Shumin Li, Yongchao Wang, Jiayu Yao, Ming Yue, Feng Jiao, Yu Wang, Meng Zhuo, Ting Han, Jiong Hu, Xiao Zhang, Jiujie Cui, Liwei Wang. Distinguishable Prognostic Signatures and Tumor Immunogenicity Between Pancreatic Head Cancer and Pancreatic Body/Tail Cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.890715
|
| 60 |
Sun Hwa Kim, Young Sik Woo, Kwang Hyuck Lee, Jong Kyun Lee, Kyu Taek Lee, Joo Kyung Park, Soo Hoon Kang, Ji Won Kim, Jae Keun Park, Sung-Wook Park. Preoperative EUS-guided FNA: effects on peritoneal recurrence and survival in patients with pancreatic cancer. Gastrointestinal Endoscopy 2018; 88(6): 926 doi: 10.1016/j.gie.2018.06.024
|
| 61 |
Zhongyu Yuan, Zhenyu Shu, Jiaxuan Peng, Wei Wang, Jie Hou, Lu Han, Guangying Zheng, Yuguo Wei, Jianguo Zhong. Prediction of postoperative liver metastasis in pancreatic ductal adenocarcinoma based on multiparametric magnetic resonance radiomics combined with serological markers: a cohort study of machine learning. Abdominal Radiology 2023; 49(1): 117 doi: 10.1007/s00261-023-04047-0
|
| 62 |
Sari F Alhasan, Beate Haugk, Laura F Ogle, Gary S Beale, Anna Long, Alastair D Burt, Dina Tiniakos, Despina Televantou, Fareeda Coxon, David R Newell, Richard Charnley, Helen L Reeves. Sulfatase-2: a prognostic biomarker and candidate therapeutic target in patients with pancreatic ductal adenocarcinoma. British Journal of Cancer 2016; 115(7): 797 doi: 10.1038/bjc.2016.264
|
| 63 |
W S Tummers, J V Groen, B G Sibinga Mulder, A Farina-Sarasqueta, J Morreau, H Putter, C J van de Velde, A L Vahrmeijer, B A Bonsing, J S Mieog, R J Swijnenburg. Impact of resection margin status on recurrence and survival in pancreatic cancer surgery. British Journal of Surgery 2019; 106(8): 1055 doi: 10.1002/bjs.11115
|
| 64 |
Emanuela Dell’Aquila, Claudia Angela Maria Fulgenzi, Alessandro Minelli, Fabrizio Citarella, Marco Stellato, Francesco Pantano, Marco Russano, Maria Concetta Cursano, Andrea Napolitano, Tea Zeppola, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini. Prognostic and predictive factors in pancreatic cancer. Oncotarget 2020; 11(10): 924 doi: 10.18632/oncotarget.27518
|
| 65 |
Zarrukh Baig, Nawaf Abu-Omar, Rayyan Khan, Carlos Verdiales, Ryan Frehlick, John Shaw, Fang-Xiang Wu, Yigang Luo. Prognosticating Outcome in Pancreatic Head Cancer With the use of a Machine Learning Algorithm. Technology in Cancer Research & Treatment 2021; 20: 153303382110507 doi: 10.1177/15330338211050767
|
| 66 |
Violette Fossaert, Antonio Mimmo, Rami Rhaiem, Linda J. Rached, Mathilde Brasseur, Mathias Brugel, Francesca Pegoraro, Stephane Sanchez, Olivier Bouché, Reza Kianmanesh, Tullio Piardi. Neoadjuvant chemotherapy for borderline resectable and upfront resectable pancreatic cancer increasing overall survival and disease-free survival?. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.980659
|
| 67 |
Louise S. Rasmussen, Mette K. Yilmaz, Ursula G. Falkmer, Laurids Ø. Poulsen, Martin Bøgsted, Heidi S. Christensen, Stig E. Bojesen, Benny V. Jensen, Inna M. Chen, Astrid Z. Johansen, Carsten P. Hansen, Jane P. Hasselby, Niels Holländer, Svend E. Nielsen, Fahimeh Andersen, Jon K. Bjerregaard, Per Pfeiffer, Julia S. Johansen. Response to the letter entitled: Re: Pre-treatment serum vitamin D deficiency is associated with increased inflammatory biomarkers and short overall survival in patients with pancreatic cancer. European Journal of Cancer 2021; 158: 248 doi: 10.1016/j.ejca.2021.09.009
|
| 68 |
Martin A. Styner, Elsa D. Angelini, Jayasree Chakraborty, Liana Langdon-Embry, Joanna G. Escalon, Peter J. Allen, Maeve A. Lowery, Eileen M. O'Reilly, Richard K. G. Do, Amber L. Simpson.
Texture analysis for survival prediction of pancreatic ductal adenocarcinoma patients with neoadjuvant chemotherapy
. Medical Imaging 2016: Image Processing 2016; 9784: 97841W doi: 10.1117/12.2214470
|
| 69 |
Weikang Liu, Yongsu Ma, Bingjun Tang, Chang Qu, Yiran Chen, Yinmo Yang, Xiaodong Tian. Predictive Model of Early Death of Resectable Pancreatic Ductal Adenocarcinoma After Curative Resection: A SEER-Based Study. Cancer Control 2022; 29: 107327482210848 doi: 10.1177/10732748221084853
|
| 70 |
Pipit Burasakarn, Anuparp Thienhiran, Pusit Fuengfoo, Sermsak Hongjinda. Analysis of preoperative risk factors for early recurrence after curative pancreatoduodenectomy for resectable pancreatic adenocarcinoma. Innovative Surgical Sciences 2022; 7(1): 5 doi: 10.1515/iss-2021-0034
|
| 71 |
Wenzhe Si, Xujun Liu, Rui Wei, Yuan Zhang, Yang Zhao, Liyan Cui, Tianpei Hong. MTA2-mediated inhibition of PTEN leads to pancreatic ductal adenocarcinoma carcinogenicity. Cell Death & Disease 2019; 10(3) doi: 10.1038/s41419-019-1424-5
|
| 72 |
Federico Armando, Adnan Fayyad, Stefanie Arms, Yvonne Barthel, Dirk Schaudien, Karl Rohn, Matteo Gambini, Mara Sophie Lombardo, Andreas Beineke, Wolfgang Baumgärtner, Christina Puff. Intratumoral Canine Distemper Virus Infection Inhibits Tumor Growth by Modulation of the Tumor Microenvironment in a Murine Xenograft Model of Canine Histiocytic Sarcoma. International Journal of Molecular Sciences 2021; 22(7): 3578 doi: 10.3390/ijms22073578
|
| 73 |
Sam Z. Thalji, Mohammed Aldakkak, Kathleen K. Christians, Callisia N. Clarke, Ben George, Mandana Kamgar, Beth A. Erickson, William A. Hall, Phillip Chisholm, Naveen Kulkarni, Saryn Doucette, Douglas B. Evans, Susan Tsai. Neoadjuvant chemotherapy for pancreatic cancer: Quality over quantity. Journal of Surgical Oncology 2023; 128(1): 41 doi: 10.1002/jso.27265
|
| 74 |
Jayasree Chakraborty, Liana Langdon-Embry, Kristen M. Cunanan, Joanna G. Escalon, Peter J. Allen, Maeve A. Lowery, Eileen M. O’Reilly, Mithat Gönen, Richard G. Do, Amber L. Simpson, Surinder K. Batra. Preliminary study of tumor heterogeneity in imaging predicts two year survival in pancreatic cancer patients. PLOS ONE 2017; 12(12): e0188022 doi: 10.1371/journal.pone.0188022
|
| 75 |
Shuichi Ota, Mamiko Miyashita, Yuka Yamagishi, Masahiro Ogasawara. Baseline immunity predicts prognosis of pancreatic cancer patients treated with WT1 and/or MUC1 peptide-loaded dendritic cell vaccination and a standard chemotherapy. Human Vaccines & Immunotherapeutics 2024; 17(12): 5563 doi: 10.1080/21645515.2021.2003645
|
| 76 |
Yu-Jen Chen, Ming-Chih Hou, Tsung-Chieh Yang, Pei-Chang Lee, Yee Chao, Chung-Pin Li, Yi-Hsiang Huang, Fa-Yauh Lee. The clinical significance of esophagogastric varices in patients with advanced pancreatic cancer. Journal of the Chinese Medical Association 2021; 84(10): 917 doi: 10.1097/JCMA.0000000000000609
|
| 77 |
Xiaoyi Huang, Xiaosong Zhi, Yisha Gao, Na Ta, Hui Jiang, Jianming Zheng. LncRNAs in pancreatic cancer. Oncotarget 2016; 7(35): 57379 doi: 10.18632/oncotarget.10545
|
| 78 |
Chenlei Wen, XiaXing Deng, Dandan Ren, Xue Song, Hao Chen, Jiancheng Wang, Jiabin Jin, Dongfeng Cheng, Zhiwei Xu, Jun Zhang, Junjie Xie, Wenjing Qi, Jiangning Gu, Chenghong Peng, Dan Chen, Shi Chen, Baiyong Shen, Qian Zhan. Tumor copy number instability is a significant predictor for late recurrence after radical surgery of pancreatic ductal adenocarcinoma. Cancer Medicine 2020; 9(20): 7626 doi: 10.1002/cam4.3425
|
| 79 |
Thijs J. Schouten, Lois A. Daamen, Galina Dorland, Stijn R. van Roessel, Vincent P. Groot, Marc G. Besselink, Bert A. Bonsing, Koop Bosscha, Lodewijk A. A. Brosens, Olivier R. Busch, Ronald M. van Dam, Arantza Fariña Sarasqueta, Sebastiaan Festen, Bas Groot Koerkamp, Erwin van der Harst, Ignace H. J. T. de Hingh, Martijn Intven, Geert Kazemier, Vincent E. de Meijer, Vincent B. Nieuwenhuijs, G. Mihaela Raicu, Daphne Roos, Jennifer M. J. Schreinemakers, Martijn W. J. Stommel, M. F. van Velthuysen, Robert C. Verdonk, Joanne Verheij, Helena M. Verkooijen, Hjalmar C. van Santvoort, I. Quintus Molenaar. Nationwide Validation of the 8th American Joint Committee on Cancer TNM Staging System and Five Proposed Modifications for Resected Pancreatic Cancer. Annals of Surgical Oncology 2022; 29(9): 5988 doi: 10.1245/s10434-022-11664-4
|
| 80 |
Tyler MacNeil, Ioannis A. Vathiotis, Saba Shafi, Thazin Nwe Aung, Jon Zugazagoitia, Aaron M. Gruver, Kyla Driscoll, David L. Rimm. Multiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes, Cancer-Associated Fibroblasts, and CD200 in Pancreatic Cancer. Cancers 2021; 13(21): 5501 doi: 10.3390/cancers13215501
|
| 81 |
Tomotaka Kato, Daisuke Ban, Ukihide Tateishi, Toshiro Ogura, Kosuke Ogawa, Hiroaki Ono, Yusuke Mitsunori, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Reticular pattern around superior mesenteric artery in computed tomography imaging predicting poor prognosis of pancreatic head cancer. Journal of Hepato-Biliary-Pancreatic Sciences 2020; 27(3): 114 doi: 10.1002/jhbp.700
|
| 82 |
Lingdi Yin, Linmei Xiao, Yong Gao, Guangfu Wang, Hao Gao, Yunpeng Peng, Xiaole Zhu, Jishu Wei, Yi Miao, Kuirong Jiang, Zipeng Lu. Comparative bioinformatical analysis of pancreatic head cancer and pancreatic body/tail cancer. Medical Oncology 2020; 37(5) doi: 10.1007/s12032-020-01370-0
|
| 83 |
Kuan-Ju Lin, Fu-Kai Hsu, Yi-Ming Shyr, Yu-Wei Ni, Mei-Yung Tsou, Kuang-Yi Chang. Effect of epidural analgesia on long-term outcomes after curative surgery for pancreatic cancer: A single-center cohort study in Taiwan. Journal of the Chinese Medical Association 2022; 85(1): 124 doi: 10.1097/JCMA.0000000000000615
|
| 84 |
Dongjun Dai, Yanmei Wang, Xinyang Hu, Hongchuan Jin, Xian Wang. Prognostic analysis of very early onset pancreatic cancer: a population-based analysis. PeerJ 2020; 8: e8412 doi: 10.7717/peerj.8412
|
| 85 |
Shengnan Li, Gengpu Zhang, Xin Li, Xiaojie Li, XiaoBing Chen, Yu Xu, He Ren. Role of the preoperative circulating tumor DNA KRAS mutation in patients with resectable pancreatic cancer. Pharmacogenomics 2021; 22(11): 657 doi: 10.2217/pgs-2020-0183
|
| 86 |
Arsen Osipov, Ognjen Nikolic, Arkadiusz Gertych, Sarah Parker, Andrew Hendifar, Pranav Singh, Darya Filippova, Grant Dagliyan, Cristina R. Ferrone, Lei Zheng, Jason H. Moore, Warren Tourtellotte, Jennifer E. Van Eyk, Dan Theodorescu. The Molecular Twin artificial-intelligence platform integrates multi-omic data to predict outcomes for pancreatic adenocarcinoma patients. Nature Cancer 2024; 5(2): 299 doi: 10.1038/s43018-023-00697-7
|
| 87 |
Jae Uk Chong, Sung Hyun Kim, Ho Kyoung Hwang, Chang Moo Kang, Woo Jung Lee. Yonsei criteria: a clinical reflection of stage I left-sided pancreatic cancer. Oncotarget 2017; 8(67): 110830 doi: 10.18632/oncotarget.22734
|
| 88 |
Jiangning Gu, Wei Xu, Chenghong Peng, Youwei Zhu, Di Wang, Xuelong Wang, Ying Li, Gang Wei, Zhiqiang Zhang, Yiming Zhong, Shulin Zhao, Minmin Shi, Dongfeng Cheng, Xiayang Ying, Jiabin Jin, Hao Chen. Perineural invasion is related to p38 mitogen‐activated protein kinase pathway activation and promotes tumor growth and chemoresistance in pancreatic cancer. Journal of Cellular Biochemistry 2019; 120(7): 11775 doi: 10.1002/jcb.28457
|
| 89 |
Cosimo Sperti, Alberto Friziero, Simone Serafini, Sergio Bissoli, Alberto Ponzoni, Andrea Grego, Emanuele Grego, Lucia Moletta. Prognostic Implications of 18-FDG Positron Emission Tomography/Computed Tomography in Resectable Pancreatic Cancer. Journal of Clinical Medicine 2020; 9(7): 2169 doi: 10.3390/jcm9072169
|